Cure8

Why This Matters

A treatable-traits approach could help tailor IBD care to each patient by targeting specific biological, comorbid, and psychosocial drivers of disease and quality-of-life impairment, potentially improving how we choose and measure treatments.

Who Should Pay Attention

Clinicians treating IBD, researchers designing personalized-medicine studies or trials, and patients interested in patient-centered, mechanism-guided care.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

The paper outlines three domains for treatable traits: gastrointestinal/intrinsic mechanisms, extraintestinal comorbidities, and psychological/behavioral factors, and emphasizes links between immune-inflammatory pathways and mental health (gut–brain axis).

It frames treatable traits as a way to connect biologic remission with patients’ quality-of-life goals and recommends using validated endpoints (for example, IBDQ) when operationalizing targets.

Keep In Mind

This article is a conceptual review (abstract-level summary provided). It proposes a framework rather than presenting new clinical trial data or validated implementation tools; additional research will be needed to operationalize and test the proposed treatable-traits model.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationEClinicalMedicine
AuthorsGraciolli Facanali CB, Carvalho CRF, Facanali MR Jr +2 more
Study typeReview, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 9, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →